• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Chemotherapeutic activity of ifosfamide in 6 different isologously transplanted experimental tumours of BD-rats (author's transl)].

作者信息

Stekar J

出版信息

Arzneimittelforschung. 1976;26(10):1793-7.

PMID:191035
Abstract

The chemotherapeutic activity of ifosfamide, applied i.v. at a high single dose, was tested on some transplantable tumours of BD-rats. As standard substance cyclophosphamide was used. The margin of safety of ifosfamide in DS-carcinosarcoma and TA-nephroblastoma was found to be wider than that of cyclophosphamide. Therefore, using massive single doses of ifosfamide, rats could be cured of DS-carcinosarcoma in higher percentage than by an analogous treatment with cyclophosphamide. Further, with a single i.v. dose of 280 mg/kg ifosfamide was it possible to cure all TA-nephroblastoma-bearing animals. The ANH-nephroblastoma, however, could not be cured even with the highest tolerable doses of ifosfamide. It was, nevertheless, possible to attain higher increase of life span over the controls than by cyclophosphamide-treatment. In some other isologous tumours ifosfamide proved to be less effective or without any activity, respectively. Pretreatment by repeated small doses of ifosfamide resulted in resistance of DS-carcinosarcoma against curative action of subsequent high single doses of this drug.

摘要

相似文献

1
[Chemotherapeutic activity of ifosfamide in 6 different isologously transplanted experimental tumours of BD-rats (author's transl)].
Arzneimittelforschung. 1976;26(10):1793-7.
2
[Treatment of the DS-carcinosarcoma in the rat with ifosfamide/dimethylsulfoxide].[用异环磷酰胺/二甲基亚砜治疗大鼠DS-癌肉瘤]
Pharmazie. 1975 Sep;30(9):602-5.
3
[Demonstration of tumor inhibiting properties of a strongly immunostimulating low-molecular weight substance. Comparative studies with ifosfamide on the immuno-labile DS carcinosarcoma. Stimulation of the autoimmune activity for approx. 20 days by BA 1, a N-(2-cyanoethylene)-urea. Novel prophylactic possibilities].[一种强免疫刺激低分子量物质的肿瘤抑制特性的证明。与异环磷酰胺对免疫不稳定的DS癌肉瘤的比较研究。N-(2-氰基乙烯)脲BA 1对自身免疫活性的刺激约20天。新的预防可能性]
Arzneimittelforschung. 1975 Sep;25(9):1369-79.
4
Comparative studies on biological activity of /+/R and /-/S enantiomers of cyclophosphamide and ifosfamide. I. Antitumour effect of cyclophosphamide and ifosfamide enantiomers.环磷酰胺和异环磷酰胺的 /+/R 及 /-/S 对映体生物活性的比较研究。I. 环磷酰胺和异环磷酰胺对映体的抗肿瘤作用。
Arch Immunol Ther Exp (Warsz). 1986;34(3):275-84.
5
[Ifosfamide in comparison with cyclophosphamide in advanced ovarian carcinomas (author's transl)].异环磷酰胺与环磷酰胺治疗晚期卵巢癌的比较(作者译)
Geburtshilfe Frauenheilkd. 1976 Mar;36(3):274-9.
6
[Therapeutic experiments with spores of strain Clostridium butyricum and Cyclophosphamide in Jensen sarcoma, Walker carcinoma, and DS carcinosarcoma of the rat (author's transl)].
Arch Geschwulstforsch. 1974;44(1):65-9.
7
[Test of multi-step-therapy of cancer (combination of pretreatment with glucose with chemotherapy and whole body hyperthermia) in Walker- and DS-carcinosarcoma of rat (author's transl)].
Arch Geschwulstforsch. 1974;43(4):310-9.
8
Results obtained with fractionated ifosfamide massive-dose treatment in generalized malignant tumours.
Int J Clin Pharmacol Biopharm. 1976 Jul;14(1):29-39.
9
Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.复发侵袭性淋巴瘤的治疗:含与不含高剂量治疗及干细胞救援的方案
Cancer Chemother Pharmacol. 2002 May;49 Suppl 1:S13-20. doi: 10.1007/s00280-002-0447-1. Epub 2002 Apr 12.
10
A phase III trial of ifosfamide with or without cisplatin in carcinosarcoma of the uterus: A Gynecologic Oncology Group Study.异环磷酰胺联合或不联合顺铂治疗子宫癌肉瘤的III期试验:一项妇科肿瘤学组研究。
Gynecol Oncol. 2000 Nov;79(2):147-53. doi: 10.1006/gyno.2000.6001.

引用本文的文献

1
Comparative activity of ifosfamide and cyclophosphamide.异环磷酰胺与环磷酰胺的活性比较
Cancer Chemother Pharmacol. 1986;18 Suppl 2:S1-9. doi: 10.1007/BF00647438.